Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study

NCT00421876 is registered in ClinicalTrials.gov with Heart Care Foundation as lead sponsor.

NCT NCT00421876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
Lead sponsor
Heart Care Foundation
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2000
Completion date
December 31, 2005
Enrollment
3,200
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction